Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT04274179
PHASE3

Ketogenic Diet for New-Onset Absence Epilepsy

Sponsor: Johns Hopkins University

View on ClinicalTrials.gov

Summary

The ketogenic diet is a medical therapy for epilepsy that is used nearly predominantly for refractory epilepsy (after 2-3 drugs have been tried and failed). However, there is both published evidence for first-line use (infantile spasms, Glut1 deficiency syndrome) and also anecdotal experience (families choosing to change the child's (or the family' own) diet rather than use anticonvulsant medications). Childhood absence epilepsy (refractory) has been published as being responsive to ketogenic diet therapy by the investigators' group previously. This is a small, prospective, 3 month trial to assess if using a modified Atkins diet is a feasible and effective option for new-onset childhood absence epilepsy. The investigators will compare to a group of children in which the parents have declined and chose to start anticonvulsant medications.

Official title: A Prospective, Case-control Evaluation of Ketogenic Dietary Therapy for New-onset Childhood Absence Epilepsy

Key Details

Gender

All

Age Range

3 Years - 12 Years

Study Type

INTERVENTIONAL

Enrollment

40

Start Date

2020-08-10

Completion Date

2026-05-01

Last Updated

2025-08-12

Healthy Volunteers

No

Interventions

OTHER

Modified Atkins Diet

Low carb (20g/day), high fat, moderate protein diet. Started as an outpatient in clinic.

DRUG

Absence epilepsy medications

At neurologist's discretion. \*OF NOTE\< THIS ARM IS COMPLETED

Locations (1)

Johns Hopkins Hospital

Baltimore, Maryland, United States